NFKB1 and neoplasm: RANKL activates NF-κB, inducing cellular proliferation by targeting cyclin D1 as illustrated in Figure 1 [17] while also while also protecting cells from apoptosis, and assisting with tumor cell renewal (Suarez 2010, Wang 2015).